|
HS Code |
320202 |
| Product Name | Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside |
| Cas Number | 106535-43-9 |
| Molecular Formula | C22H25NO6 |
| Molecular Weight | 399.44 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in chloroform, methanol |
| Melting Point | 150-155°C |
| Storage Temperature | 2-8°C (Refrigerated) |
| Purity | Typically ≥98% |
| Synonyms | Benzyl N-acetyl-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside |
| Smiles | CC(=O)N[C@@H]1C(O[C@@H](COC6=CC=CC=C6)[C@H](O)[C@H](O)[C@H]1OC2C=CC=CC2=O)=O |
| Inchi Key | LPVJABPXVBNGPH-CHBJZPLNSA-N |
| Usage | Glycosyl donor/intermediate in carbohydrate synthesis |
As an accredited Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, 5 grams, sealed with screw cap; labeled with product name, purity, CAS number, and hazard warnings. |
| Shipping | Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside is shipped in tightly sealed containers, protected from moisture and light. It is handled as a non-hazardous chemical under normal conditions, but should be transported according to standard laboratory chemical protocols, including temperature control if required, and with appropriate documentation for traceability and safety compliance. |
| Storage | Store Benzyl 2-Acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside in a tightly sealed container, protected from light and moisture, in a cool, dry place (2–8°C, refrigerator recommended). Avoid exposure to strong oxidizing agents. Ensure that the storage area is well-ventilated and clearly labeled. Follow proper chemical hygiene and local regulations for storage and handling. |
Applications of Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside in Industrial ManufacturingBenzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside serves specialized functions in targeted chemical synthesis. Its well-defined protecting group pattern and reactivity profile make it a valuable intermediate for high-purity end uses, especially in the sectors of pharmaceutical intermediates, oligosaccharide synthesis, enzyme substrate development, advanced diagnostic reagent production, and glycoconjugate research. As a manufacturer, we recognize its unique roles in these applications and maintain process integrity for each industrial context. 1. Pharmaceutical Glycosyl Donor for Nucleoside Analog SynthesisThis glycoside acts as a protected glucosyl donor in multi-step routes for nucleoside analogs, which are prominent in antiviral and anticancer therapies. Its selective protection groups enable programmable deprotection and glycosidic bond formation under precise catalytic conditions. Downstream pharmaceutical plants demand strict source control, analytical traceability, and contaminant profiling at each batch stage to comply with drug master file submission. The intermediate integrates into the synthesis during the stage where the protected glycosyl moiety is coupled to nucleobases via Lewis acid-catalyzed reactions and is later transformed to unprotected sugar frameworks for API completion. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Oligosaccharide Synthesis Intermediate in Glycobiology ResearchThe compound’s stable acetyl and benzylidene protection makes it a critical starter unit or extension donor during complex oligosaccharide assembly, utilized in both academic and industrial glycobiology labs. Its orthogonal protection allows for regioselective coupling, essential for constructing branched glycan motifs. Users require batch-specific data verifying residual solvent, heavy metal content, and absence of related monosaccharide impurities. Its introduction to automated or manual solid-phase synthesis platforms ensures repetitive high-yield coupling for therapeutic glycan and glycan-protein conjugate investigations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Enzyme Substrate Development for Glycosidase AssaysThis compound functions as a derivatized glucopyranoside substrate for characterization of glycosidase enzyme activity, a need in both biopharmaceutical QC labs and diagnostic kit production. The benzylidene and benzyl groups resist nonspecific hydrolysis, supporting controlled kinetic experiments. QC teams require low endotoxin levels and validated absence of free amines to reduce background in fluorescence or colorimetric detection. Manufacturers blend it with appropriate label partners at defined ratios, and incorporate into buffered assay preparations for standardized enzyme activity quantification. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Diagnostic Reagent Precursor (Glycan Labeling)In specialty diagnostic production, this protected glucopyranoside acts as a precursor for custom glycan labeling reagents. Its functional groups support orthogonal deprotection and controlled functionalization, enabling chemical coupling to biotin, fluorescent tags, or radioactive groups. Diagnostic formulation labs scrutinize every lot for isomeric purity and batch stability, as small deviations can affect labeling performance. The raw material integrates at the conjugation stage, after partial deprotection, followed by purification and covalent labeling. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Glycoconjugate API Reference Standard ProductionIndustry and regulatory laboratories utilize this protected glucopyranoside in the preparation of certified reference materials (CRMs) for glyco-pharmaceuticals and biologics. The material’s structural precision supports traceable batch synthesis, critical when validating biologic APIs with complex glycosylation patterns. Reference standard producers require thorough spectroscopic identity profiling and cross-validation with NMR and MS. The compound enters multi-step synthesis as the foundational glycoside, followed by controlled deprotection or further glycosylation to match the structure of clinical product lots. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Across decades of chemical production, our hands have shaped carbohydrates into the building blocks for research and industry. Among scores of custom syntheses, one specialty captures both attention and respect: Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside. Long before this “mouthful” became a trusted reagent for carbohydrate chemistry, our team worked through its intricate synthesis, from the stabilization of sensitive intermediates to the preservation of fine chiral integrity at every step. There’s always been a reason scientists insist on reliable sources for such compounds—contaminated batches, racemization issues, or poorly controlled moisture all change the outcome of next-stage chemistry. The truth is, when glycosyl donors and acceptors fall short of purity or integrity, entire research programs can veer off track.
We put our name on Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside by building in quality checkpoints right from the first benzylidene protection. There’s a science to controlling reaction conditions—too hot, and the benzylidene opens; too cold, and yields drop or impurities persist. Our reactors deliver consistent batches, refined at scale, and our analytical chemists use validated HPLC, NMR, and mass spectrometry data to certify every lot. Customers from academic and pharma settings consistently tell us the identity and purity—regularly above 98%—give them the repeatability they count on. Everyone claims high-quality products in the abstract, but as a chemical manufacturer, we know a failed coupling reaction can waste weeks of effort. Quality and transparency keep researchers coming back, not marketing speak.
Synthesizing oligosaccharides means choosing protecting groups that do more than just block reactive sites. The dual protection—an acetamido at C-2 and benzylidene at 4,6—delivers both orthogonality and stability. We’ve spent years meeting requests from glycoscientists who need robust blocking at C-4 and C-6 without sacrificing selectivity during downstream modifications. Other materials lacking proper protection elsewhere can compromise yield during glycosylation or leave unprotected hydroxyls vulnerable to side-reactions. The stable benzylidene ring in this molecule resists mild acid and base, offering reliable selectivity for stepwise manipulation. The benzyl group at the anomeric position, introduced via catalytic hydrogenation under rigorously controlled conditions, ensures clean separation from over-reduced or β-linked byproducts. Labs demand properly protected glycosides for reliable disaccharide and oligosaccharide assembly; even a small percentage of deprotected impurity can sabotage scale-up or lead to ambiguous NMR signals.
Unlike generic offerings, our Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside undergoes batch-specific certification, including physicochemical and analytical identity checks. Sampling every vessel avoids “hot spots” of contamination left over from pilot runs. Chromatographic fingerprinting and chiral analysis confirm the absence of α/β isomers outside specification. From the kilo lab to larger campaigns, every stage brings its own headache—solvent residues must evaporate completely, and the last steps risk introducing moisture that ruins shelf stability. When research groups advance to regulated environments, they look for traceability and documentation beyond simple COAs; they ask for comprehensive lot histories and raw data, and we stay ready to supply that. This level of detail isn’t just a compliance box—it’s the difference between a publishable result and a retraced project.
Discussions with carbohydrate chemists usually jump straight to the challenges of glycosyl donor installation. The benzyl-protected glycoside stands within a class of intermediates enabling glycosylation with mild activation, which prevents undesired rearrangement or degradation seen with more labile leaving groups. Whether a group works in vaccine adjuvant discovery or studies bacterial oligosaccharide arrays, they ask about the reliability of the benzyl protecting group—ours support reproducible activation in both small-scale and process development campaigns. The N-acetyl group at C-2 blocks potential migration and gives access to N-linked glycoside analogs, a key feature for modeling biological glycoconjugates. Our feedback loop with end-users, from postdocs to process chemists, shapes specification refinement year after year.
The α-linkage at the anomeric center matters for bioactivity in next-generation therapeutics and diagnostics. We’ve invested years in optimizing catalysts, solvents, and temperature ramps to favor the α-anomer, minimizing β-anomer formation. A few percent β-contamination can kill selectivity in glycosylation or create intractable mixtures in bioassays. NMR data are supplied with each lot, and we encourage researchers to scrutinize coupling constants and chemical shifts. Failures in selectivity often trace back to weak in-process controls during anomeric deprotection or benzyl group installation—there’s no substitute for experienced hands at the bench and robust equipment for scale-up. Alpha-selective synthesis delivers confidence downstream; it removes ambiguity that shows up only after time-consuming purification efforts later in the synthetic route.
Consistent product depends on consistent raw material. The glucosamine hydrochloride feedstock comes from rigorously screened sources, and we carry out initial deprotection and re-protection steps under carefully monitored humidity and temperature environments. Even minor lot-to-lot changes in substrate lead to surprising shifts in overall reactivity, especially on scale. Suppliers with vague quality control pass the risk onto their customers. In our shop, raw material histories and certificates stack up for every delivery. This chain of custody guarantees each batch traces back to the same high-quality origins—our team learned the hard way that new suppliers or inconsistent feedstocks stall scale-up and bring unpredictable analytical profiles.
Carbohydrate intermediates attract water, and moisture unlocks hidden reactivity that spoils material during storage or transit. From the first days in production, we moved away from the “just dry it again” mentality. Controlled environmental packaging—sealed under inert gas, with tamper-evident containers—keeps product dry and ready for use. Any exposure triggers rigorous retesting. Incoming feedback from long-term customers highlights the importance of a clean, free-flowing powder, not the dense, clumpy material pulled from poorly sealed drums. Every operator understands why careful moisture monitoring stands alongside analytical testing. This attention to detail supports not only current research, but also future manufacturing scale-up by maintaining material quality across months or years.
Much discussion comes from newcomers to the field who ask about the “best” protecting group for specific applications. Over the years, we’ve handled methyl, silyl, acetyl, and p-methoxybenzyl protection strategies—each suits a niche, but none matches the broad stability and mild deprotection profile of benzyl/benzylidene. The benzyl group comes off under classic catalytic hydrogenation, removing itself completely without eroding sensitive backbones. Benzylidene rings can be cleaved specifically, opening the way for selective hydroxyl group manipulation not possible with silyl or simple acyl protection. Certain research tasks require temporary protection, and we’ve fielded requests for faster cleaving groups, but those sacrifices usually mean lower yields, extra steps, or impurity headaches. Our experience informs advice to our customers—don’t chase convenience at the expense of reliability.
Years ago, production processes often led to excess solvent waste and energy use. Our current process minimizes waste through continuous solvent recovery and recycling. For example, the DCM and toluene washings generated in benzylidene installation now feed into our onsite recovery units, reducing both input costs and environmental burden. We swap out less environmentally friendly reagents where performance and product quality remain unaffected—a solution made possible after collaborative efforts between our synthetic teams and environmental compliance specialists. This push isn’t just for regulatory reasons; the cost of waste disposal and compliance compels every responsible manufacturer to find better alternatives.
Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside enables precise assembly of glycoconjugates used in everything from pathogen typing arrays to targeted immunotherapies. Leading research teams and biotech innovators depend on it as a foundation for constructing complex oligosaccharides with minimal byproduct risk. Further downstream, pharma groups leverage its clean activation profile to develop synthetic vaccines and glycopeptide mimetics. Diagnostic kit developers use it as a scaffold for conjugation, relying on consistent lot quality for reproducible analytical results. In all these arenas, direct dialogue with users uncovers new needs—we listen and adapt, offering technical guidance based on actual manufacturing experience rather than speculation.
No chemical operation succeeds in the long term without a strong safety record. Our manufacturing team trains on every piece of equipment and every process, from pressure reactors to chromatographic columns. We regularly review hazard control for every reagent and step, not merely to check a box for auditors, but to protect the hands and eyes doing the real work. Benzyl and benzylidene chemistry calls for careful monitoring of catalysts to prevent runaway exotherms. Over the years, refinements in process control have come directly from shop-floor feedback—batch monitoring, slow addition protocols, dry-ice condensers—all add layers of safety and risk mitigation. This culture has allowed us to run larger campaigns with fewer interruptions. Workers share their observations, leading to process tweaks that cut down on off-spec product before it ever leaves the reactor.
Our best process changes often spring from customer troubleshooting. Routine discussions with research chemists flagged earlier issues with benzyl group stability during storage; as a direct result, we shifted to purging drums with nitrogen through the entire packaging line. A biopharma partner’s problem with scale-up revealed a thermal gradient in the first-generation reactor—after internal review, we rebuilt the jacket design, yielding tighter control of the benzylidene step at all batch sizes. Every piece of feedback, whether on granule flow, color, or analytical profile, gets discussed by production, QA, and applications support. Some improvements require months of validation, others take only a quick equipment swap, but all center on supporting client success and material reliability. The cycle never truly ends—we’re ready to troubleshoot with every collaborator, recognizing that no synthetic route stays static in this evolving field.
While the majority of usage lands within research synthesis and early-stage drug development, new horizons keep emerging. Automated glycan assembly pushes for faster, more tolerant intermediates. We’re working alongside early adopters to adapt process conditions that fit into these new platforms. The inherent versatility of our product derives from its well-designed protection pattern, but integration into robotics means even higher standards for physical and chemical consistency—flowability, thermal stability, and resistance to static all get reviewed. This demand for performance is a wake-up call for any company stuck in yesterday’s processes. By investing in both analytical upgrades and personnel training, we stay ready for these fresh waves of technological progress.
The shift toward regulated industry applications—whether in GMP research, diagnostic kit validation, or pharma development—motivates steady improvement in batch analytical control. Each batch earns full-release QC reports, not just high-level summaries. NMR archives demonstrate both purity and full structural integrity, including subtle chemical shift patterns around the anomeric position. HPLC assessments provide detection and quantitation of minor impurities, supporting both individual researcher protocols and large-scale development plans. Regulatory scrutiny in the scientific world shows no signs of letting up, and our in-house QA knows the language and rigor needed for international partnerships. Analytical transparency is more than a marketing promise; researchers have entire programs riding on trust in what they receive. In rare cases where results don’t match spec, our QA team investigates, not with canned apologies but through root-cause analysis and prompt, real-world solutions.
It’s easy to forget how much institutional know-how lives in the hands of experienced staff. Many members of our team have run batches of Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside for years, refining details in filtration, solvent exchange, and storage. This commitment shows in process yield improvements and spot decisions during weather or equipment upsets. One team member recently devised a subtle agitation schedule that eliminated a troublesome batch-to-batch color variation—a fix that eluded even the most advanced process models. This experience doesn’t come from paper SOPs alone. Skilled operators spot the early signs of racemization, incomplete benzylidene protection, or low-level water ingress long before analytics flag a problem. Staff take pride in every customer success story and view process reliability as their own responsibility.
No manufacturer advances alone. Over the years, our progress mirrored the feedback and partnership with users worldwide. Product innovations arose not from chasing trends, but from answering real requirements. Facing scale-up hurdles, advanced instrument installs, and increasingly strict regulatory audits, we rely on both internal expertise and open exchange with clients. Each order carries not just material, but the weight of mutual trust earned through years of consistent delivery. Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside stands as a testament to our commitment to the disciplines of organic chemistry, pharmaceutical development, and glycosciences.
Research doesn’t stand still. As labs demand higher throughput screening, customizable oligosaccharide libraries, or expanded conjugation chemistries, our product line follows. Internal R&D teams constantly review literature and experiment alongside top academic collaborators, refining not just synthetic methods but also how we support documentation, stability, and real-world usability. Our own development process—rooted in careful experimentation and open discussion—reinforces trust with future partners. Supporting a new wave of scientists depends on the willingness to evolve, troubleshoot, and share our manufacturing journey. Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-Alpha-D-Glucopyranoside continues to embody that ongoing conversation between reliable manufacturing, rigorous science, and genuine collaborative spirit.